Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Jennifer Kern, Sliwa"'
Autor:
Christoph U. Correll, Amber Martin, Charmi Patel, Carmela Benson, Rebecca Goulding, Jennifer Kern-Sliwa, Kruti Joshi, Emma Schiller, Edward Kim
Publikováno v:
npj Schizophrenia, Vol 8, Iss 1, Pp 1-10 (2022)
Abstract Clinical practice guidelines (CPGs) translate evidence into recommendations to improve patient care and outcomes. To provide an overview of schizophrenia CPGs, we conducted a systematic literature review of English-language CPGs and synthesi
Externí odkaz:
https://doaj.org/article/f378dd198d984b11ab3a7782b1dff956
Autor:
Srihari Gopal, Christoph U. Correll, Maju Mathews, Stephen R. Saklad, Wayne Hamm, Raja Venkatasubramanian, Jennifer Kern Sliwa, Edward Kim
Publikováno v:
CNS Drugs
The availability of long-acting injectable (LAI) antipsychotics for the treatment of schizophrenia provides clinicians with options that deliver continuous drug exposure and may improve adherence compared with daily oral antipsychotics. However, all
Autor:
Arun Singh, Edward Kim, Annette Wooller, Ibrahim Turkoz, Jennifer Kern-Sliwa, Jesse A. Berlin, Maju Mathews, Srihari Gopal
Publikováno v:
International Clinical Psychopharmacology. 33:213-216
In a recent study, an indirect treatment comparison was performed to examine the relative efficacy and tolerability of aripiprazole once monthly and paliperidone palmitate once monthly. The authors concluded that the results may suggest relative adva
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 26:568-569
DISCLOSURES: The writing of this letter was supported by Janssen Scientific Affairs. The authors are employees of Janssen Scientific Affairs or Janssen Global Services (Johnson & Johnson).
Publikováno v:
Journal of psychosocial nursing and mental health services. 57(11)
Publikováno v:
CNS spectrums. 24(4)
With more long-acting injectable (LAI) antipsychotics available for treating schizophrenia, each with variable durations of action (2 weeks to 3 months), it is important to have clear management strategies for patients developing breakthrough psychot
Autor:
Arun Singh, Edward Kim, Alberto Russu, Jennifer Kern Sliwa, Paulien Ravenstijn, Maju Mathews, Srihari Gopal
Publikováno v:
International Journal of Clinical Practice
Summary Aim We assessed the dosage strengths of paliperidone palmitate 1‐month (PP1M) long‐acting injectable resulting in similar steady‐state (SS) exposures to the dosage strengths of oral risperidone using pharmacokinetic (PK) simulations. Me
Autor:
Adam Savitz, Jennifer Kern Sliwa, Srihari Gopal, Isaac Nuamah, Larry Alphs, Erica Elefant, Maju Mathews, Dean Najarian
Publikováno v:
Perspectives in psychiatric care. 54(4)
Purpose To evaluate injection site reactions and pain following paliperidone palmitate 1-month (PP1M) and 3-month (PP3M) administration using safety data of double-blind (DB), noninferiority study. Methods Patients (n = 1,429) with schizophrenia, tre
Publikováno v:
Early intervention in psychiatry. 10(5)
Publikováno v:
Current Drug Metabolism. 11:516-525
Background: The metabolic/biotransformation pathways of atypical antipsychotics (aripiprazole, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) have been characterized and reviewed. However, comparisons of e